These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4232910)

  • 21. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.
    Okada K; Ueda K; Morokuma K; Kino Y; Tokugawa K; Nishima S
    Jpn J Infect Dis; 2004 Apr; 57(2):67-71. PubMed ID: 15118214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood and plasma preservatives as carriers of homologous tetanus antitoxin].
    Eckmann L
    Bibl Haematol; 1967; 27():268-9. PubMed ID: 5595092
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
    Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prevention of tetanus].
    Chaput A
    Inf Dent; 1968 Apr; 50(14):1433-4. PubMed ID: 5243577
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficiency of tetanus toxoid booster in leukaemic children.
    Nyerges G; Zimonyi I; Nyerges G; Mészner Z; Marosi A
    Acta Paediatr Acad Sci Hung; 1981; 22(3):237-41. PubMed ID: 6272539
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-tetanus vaccines].
    Bizzini B
    Boll Ist Sieroter Milan; 1983; 62(6):550-4. PubMed ID: 6677267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 29. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.
    Cumberland P; Shulman CE; Maple PA; Bulmer JN; Dorman EK; Kawuondo K; Marsh K; Cutts FT
    J Infect Dis; 2007 Aug; 196(4):550-7. PubMed ID: 17624840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum levels of tetanus antibodies in tetanus patients treated with tetanus antitoxin and toxoid].
    Januszkiewicz J; Galazka A; Adamczyk J; Sporzyńska Z
    Przegl Epidemiol; 1974; 28(2):149-58. PubMed ID: 4849698
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of tetanus. Experimental trial in guinea pigs with serum, toxoid and serotoxoid].
    Corrêa A; Tavares J
    Rev Inst Med Trop Sao Paulo; 1972; 14(4):246-8. PubMed ID: 5084219
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunogenicity of tetanus toxoid used in conjunction with high doses of tetanus antitoxin].
    Galazka A; Januszkiewicz J; Sporzyńska Z; Adamczyk J
    Przegl Epidemiol; 1974; 28(3):345-53. PubMed ID: 4409780
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunity against diphtheria and tetanus in German blood donors.
    Aue A; Hennig H; Krüger S; Closius B; Kirchner H; Seyfarth M
    Med Microbiol Immunol; 2003 May; 192(2):93-7. PubMed ID: 12736822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Formation of antitetanus immunity in trauma].
    Matveev KI; Sergeeva TI; Petrov PN; Kasparova EM
    Khirurgiia (Mosk); 1970 Sep; 46(9):113-8. PubMed ID: 5496626
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tetanus and tetanus rapid-immunization].
    Koch W
    Zentralbl Chir; 1967 Nov; 92(45):2799-804. PubMed ID: 5591485
    [No Abstract]   [Full Text] [Related]  

  • 36. A new outlook on the prophylaxis of tetanus: immunization by the digestive route.
    Veronesi R; Corrêa A; Tavares J
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(3):123-8. PubMed ID: 5038987
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
    Parkkali T; Olander RM; Ruutu T; Vuontela K; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1997 May; 19(9):933-8. PubMed ID: 9156269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of anti-tetanus human IgG by immunoadsorption.
    Varró R; Richter P; Thury I
    Ann Immunol Hung; 1973; 17():39-43. PubMed ID: 4218937
    [No Abstract]   [Full Text] [Related]  

  • 39. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative studies on the rate of absorption after subcutaneous and intramuscular injection of tetanus antitoxin.
    CHRISTENSEN PE
    Acta Pathol Microbiol Scand; 1952; 31(2):262-74. PubMed ID: 14933103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.